HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

Heart Rhythm

Volumn 11, Issue 7, 2014, Pages 1304-1323

  Birnie, David H ^a   Sauer, William H ^b   Bogun, Frank ^c   Cooper, Joshua M ^d   Culver, Daniel A ^e   Duvernoy, Claire S ^c   Judson, Marc A ^f   Kron, Jordana ^g   Mehta, Davendra ^h   Cosedis Nielsen, Jens ⁱ   Patel, Amit R ^j   Ohe, Tohru ^k   Raatikainen, Pekka ^l   Soejima, Kyoko ^a,m  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f ALBANY MEDICAL COLLEGE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j UNIVERSITY OF CHICAGO   (United States)

^k THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

^l TAMPERE UNIVERSITY HOSPITAL   (Finland)

^m KYORIN UNIVERSITY   (Japan)

more..

Author keywords

Atrial arrhythmias; Catheter ablation; Heart block; Immunosuppression; Implantable cardioverter defibrillator; Risk stratification; Sarcoidosis; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CONSENSUS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ELECTROSTIMULATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE DYSPLASIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SCREENING; SUDDEN CARDIAC DEATH; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CONSENSUS DEVELOPMENT;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; HUMANS; SARCOIDOSIS;

EID: 84903119424     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.03.043     Document Type: Article

References (99)

1. D.S. McGrath, N. Goh, P.J. Foley, and R.M. du Bois Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 18 2001 149 164
2. Statement on sarcoidosis Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 1999 736 755
3. T. Morimoto, A. Azuma, and S. Abe et al. Epidemiology of sarcoidosis in Japan Eur Respir J 31 2008 372 379
4. G. Hillerdal, E. Nou, K. Osterman, and B. Schmekel Sarcoidosis: epidemiology and prognosis. A 15-year European study Am Rev Respir Dis 130 1984 29 32
5. D. Valeyre, A. Prasse, H. Nunes, Y. Uzunhan, P.Y. Brillet, and J. Muller-Quernheim Sarcoidosis Lancet 2013 September 30
6. L.S. Newman, C.S. Rose, and L.A. Maier Sarcoidosis N Engl J Med 336 1997 1224 1234
7. J.C. Grutters, and J.M. van den Bosch Corticosteroid treatment in sarcoidosis Eur Respir J 28 2006 627 636
8. H.L. Israel, and J.E. Gottlieb Outcome of the treatment for sarcoidosis Am J Respir Crit Care Med 151 1995 920 921
9. T. Izumi Sarcoidosis in Kyoto (1963-1986) Sarcoidosis 5 1988 142 146
10. N.S. Paramothayan, T.J. Lasserson, and P.W. Jones Corticosteroids for pulmonary sarcoidosis Cochrane Database Syst Rev 2 2005 CD001114
11. U.S. Ayyala, A.P. Nair, and M.L. Padilla Cardiac sarcoidosis Clin Chest Med 29 2008 493 508 ix
12. S.W. Dubrey, and R.H. Falk Diagnosis and management of cardiac sarcoidosis Prog Cardiovasc Dis 52 2010 336 346
13. C. Chapelon-Abric, D. de Zuttere, and P. Duhaut et al. Cardiac sarcoidosis: a retrospective study of 41 cases Medicine (Baltimore) 83 2004 315 334
14. H.A. Fleming, J.N. McMahon, C.F. McCarthy, and P. Kelehan Sarcoid heart disease Br Heart J 50 1983 498
15. Y. Matsui, K. Iwai, and T. Tachibana et al. Clinicopathological study of fatal myocardial sarcoidosis Ann N Y Acad Sci 278 1976 455 469
16. W.C. Roberts, H.A. McAllister Jr, and V.J. Ferrans Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) Am J Med 63 1977 86 108
17. J.P. Smedema, G. Snoep, and M.P. van Kroonenburgh et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands Chest 128 2005 30 35
18. Y. Yazaki, M. Isobe, and M. Hiroe et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone Am J Cardiol 88 2001 1006 1010
19. P. Uusimaa, K. Ylitalo, and O. Anttonen et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis Europace 10 2008 760 766
20. K. Iwai, T. Tachibana, T. Takemura, Y. Matsui, M. Kitaichi, and Y. Kawabata Pathological studies on sarcoidosis autopsy, I: epidemiological features of 320 cases in Japan Acta Pathol Jpn 43 1993 372 376
21. K. Iwai, T. Takemura, M. Kitaichi, Y. Kawabata, and Y. Matsui Pathological studies on sarcoidosis autopsy, II: early change, mode of progression and death pattern Acta Pathol Jpn 43 1993 377 385
22. A. Perry, and F. Vuitch Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations Arch Pathol Lab Med 119 1995 167 172
23. O. Vignaux, R. Dhote, and D. Duboc et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study J Comput Assist Tomogr 26 2002 762 767
24. M.R. Patel, P.J. Cawley, and J.F. Heitner et al. Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
25. D. Mehta, S.A. Lubitz, and Z. Frankel et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing Chest 133 2008 1426 1435
26. R. Dhôte, O. Vignaux, and P. Blanche et al. [Value of MRI for the diagnosis of cardiac involvement in sarcoidosis] Rev Med Interne 24 2003 151 157
27. J.S. Kim, M.A. Judson, and R. Donnino et al. Cardiac sarcoidosis Am Heart J 157 2009 9 21
28. M. Sekiguchi, Y. Numao, M. Imai, T. Furuie, and R. Mikami Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis: concepts through a study employing endomyocardial biopsy, I: sarcoidosis Jpn Circ J 44 1980 249 263
29. M.M. Sadek, D. Yung, D.H. Birnie, R.S. Beanlands, and P.B. Nery Corticosteroid therapy for cardiac sarcoidosis: a systematic review Can J Cardiol 29 2013 1034 1041
30. C.Z. Chiu, S. Nakatani, and G. Zhang et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis Am J Cardiol 95 2005 143 146
31. S. Greulich, C.C. Deluigi, and S. Gloekler et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis JACC Cardiovasc Imaging 6 2013 501 511
32. A.R. Patel, M.R. Klein, and S. Chandra et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study Eur J Heart Fail 13 2011 1231 1237
33. Judson MA. The WASOG Sarcoidosis Organ Assessment Instrument Investigators. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diff Lung Dis. In press.
34. Hiraga H, Yuwai K, Hiroe M, et al. Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases From the Japanese Ministry of Health and Welfare. Tokyo: Japanese Ministry of Health and Welfare, 1993;23-24
35. Diagnostic standard and guidelines for sarcoidosis Jpn J Sarcoidosis Granulomatous Disorders 27 2007 89 102
36. M.A. Judson, R.P. Baughman, A.S. Teirstein, M.L. Terrin, and H. Yeager Jr Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 16 1999 75 86
37. M.A. Judson, B.W. Thompson, and D.L. Rabin et al. The diagnostic pathway to sarcoidosis Chest 123 2003 406 412
38. A. Ichinose, H. Otani, and M. Oikawa et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function AJR Am J Roentgenol 191 2008 862 869
39. K.W. Cummings, S. Bhalla, C. Javidan-Nejad, A.J. Bierhals, F.R. Gutierrez, and P.K. Woodard A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging Radiographics 29 2009 89 103
40. 18F-FDG J Nucl Med 46 2005 1522 1530
41. 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 2004 1989 1998
42. 18F-FDG PET-CT in the detection of cardiac sarcoidosis J Nucl Cardiol 16 2009 801 810
43. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
44. H. Ardehali, D.L. Howard, and A. Hariri et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy Am Heart J 150 2005 459 463
45. L.T. Cooper, K.L. Baughman, and A.M. Feldman et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2007 2216 2233
46. P.B. Nery, A. Keren, J. Healey, E. Leug, R.S. Beanlands, and D.H. Birnie Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy Can J Cardiol 2012 December 13
47. R. Kandolin, J. Lehtonen, and M. Graner et al. Diagnosing isolated cardiac sarcoidosis J Intern Med 2011 May 2
48. O. Leone, J.P. Veinot, and A. Angelini et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology Cardiovasc pathol 21 2012 245 274
49. A.M. Freeman, D. Curran-Everett, and H.D. Weinberger et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies Am J Cardiol 112 2013 280 285
50. J.L. Schuller, C.M. Lowery, and M. Zipse et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis Ann Noninvasive Electrocardiol 16 2011 70 76
51. J.L. Schuller, M.D. Olson, and M.M. Zipse et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement J Cardiovasc Electrophysiol 22 2011 1243 1248
52. R. Kandolin, J. Lehtonen, and M. Kupari Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults Circ Arrhythm Electrophysiol 4 2011 303 309
53. Nery PB, Beanlands RS, Nair G, et al. Middle aged patients with new onset atrioventricular block should be investigated for cardiac sarcoidosis. Heart Rhythm 2013 January 5;10:S447.
54. P.B. Nery, B.A. Mc Ardle, and C.J. Redpath et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia Pacing Clin Electrophysiol 2013 September 17
55. B.A. Koplan, K. Soejima, K. Baughman, L.M. Epstein, and W.G. Stevenson Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation Heart Rhythm 3 2006 924 929
56. P.A. Santucci, J.B. Morton, M.M. Picken, and D.J. Wilber Electroanatomic mapping of the right ventricle in a patient with a giant epsilon wave, ventricular tachycardia, and cardiac sarcoidosis J Cardiovasc Electrophysiol 15 2004 1091 1094
57. S.C. Vasaiwala, C. Finn, and J. Delpriore et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia J Cardiovasc Electrophysiol 20 2009 473 476
58. D.G. Dechering, S. Kochhauser, and K. Wasmer et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy Heart Rhythm 10 2013 158 164
59. D.A. Steckman, P.M. Schneider, and J.L. Schuller et al. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy Am J Cardiol 110 2012 575 579
60. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary Heart Rhythm 5 2008 934 955
61. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 127 2013 e283 e352
62. E. Erdmann [Angina pectoris, pathological stress EKG and a normal coronary angiogram] Internist (Berl) 21 1980 165 168
63. H. Okamoto, K. Mizuno, and E. Ohtoshi Cutaneous sarcoidosis with cardiac involvement Eur J Dermatol 9 1999 466 469
64. Y. Kato, S. Morimoto, A. Uemura, S. Hiramitsu, T. Ito, and H. Hishida Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block Sarcoidosis Vasc Diffuse Lung Dis 20 2003 133 137
65. K. Banba, K.F. Kusano, and K. Nakamura et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis Heart Rhythm 4 2007 1292 1299
66. K. Yodogawa, Y. Seino, T. Ohara, H. Takayama, T. Katoh, and K. Mizuno Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis Ann Noninvasive Electrocardiol 16 2011 140 147
67. L.S. Wann, A.B. Curtis, and C.T. January et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 223 242
68. A.J. Camm, G.Y. Lip, and C.R. De et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
69. H. Golwala, and T. Dernaika Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: a case report and review of the literature J Cardiovasc Med (Hagerstown) 2011 January 19
70. J.F. Viles-Gonzalez, L. Pastori, A. Fischer, J.P. Wisnivesky, M.G. Goldman, and D. Mehta Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications Chest 143 2013 1085 1090
71. M.M. Zipse, J. Schuller, and J.T. Katz et al. Atrial arrhythmias are common and arise from diverse mechanisms in patients with cardiac sarcoidosis Heart Rhythm 10 2013 S309
72. J.L. Schuller, M. Zipse, and T. Crawford et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis J Cardiovasc Electrophysiol 23 2012 925 929
73. B.P. Betensky, C.M. Tschabrunn, and E.S. Zado et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators Heart Rhythm 9 2012 884 891
74. J. Kron, W. Sauer, and J. Schuller et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis Europace 15 2013 347 354
75. N. Namboodiri, M.K. Stiles, G.D. Young, and P. Sanders Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases Indian Pacing Electrophysiol J 12 2012 284 289
76. U.N. Srivatsa, and J. Rogers Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation Indian Pacing Electrophysiol J 12 2012 290 291
77. J.J. Swigris, A.L. Olson, and T.J. Huie et al. Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007 Chest 140 2011 1261 1266
78. D.S. Echt, P.R. Liebson, and L.B. Mitchell et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
79. E.M. Aliot, W.G. Stevenson, and J.M. Almendral-Garrote et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm 6 2009 886 933
80. D. Jefic, B. Joel, and E. Good et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry Heart Rhythm 6 2009 189 195
81. B. Berte, B. Eyskens, G. Meyfroidt, and R. Willems Bidirectional ventricular tachycardia in fulminant myocarditis Europace 10 2008 767 768
82. Y.T. Tai, C.P. Lau, P.C. Fong, J.P. Li, and K.L. Lee Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis Cardiology 80 1992 339 344
83. C.S. Stees, M.S. Khoo, C.M. Lowery, and W.H. Sauer Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis J Cardiovasc Electrophysiol 2010 June 17
84. E.V. Tselentakis, E. Woodford, J. Chandy, G.R. Gaudette, and A.E. Saltman Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation J Surg Res 135 2006 68 75
85. H. Futamatsu, J. Suzuki, and S. Adachi et al. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia Int J Cardiovasc Imaging 22 2006 443 448
86. S.L. Winters, M. Cohen, and S. Greenberg et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device J Am Coll Cardiol 18 1991 937 943
87. H. Furushima, M. Chinushi, H. Sugiura, H. Kasai, T. Washizuka, and Y. Aizawa Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome Clin Cardiol 27 2004 217 222
88. S. Hiramitsu, S. Morimoto, and A. Uemura et al. National survey on status of steroid therapy for cardiac sarcoidosis in Japan Sarcoidosis Vasc Diffuse Lung Dis 22 2005 210 213
89. F.M. Bogun, B. Desjardins, and E. Good et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate J Am Coll Cardiol 53 2009 1138 1145
90. M. Kuhne, G. Abrams, and J.F. Sarrazin et al. Isolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathy J Cardiovasc Electrophysiol 21 2010 1017 1023
91. D. Mehta, N. Mori, S.H. Goldbarg, S. Lubitz, J.P. Wisnivesky, and A. Teirstein Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation Circ Arrhythm Electrophysiol 4 2011 43 48
92. A. Aizer, E.H. Stern, J.A. Gomes, A.S. Teirstein, R.E. Eckart, and D. Mehta Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis Am J Cardiol 96 2005 276 282
93. C.M. Kramer, J. Barkhausen, S.D. Flamm, R.J. Kim, and E. Nagel Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update J Cardiovasc Magn Reson 15 2013 91
94. Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2013;October 1.
95. 18F- fluorodeoxyglucose positron emission tomography? Circ Cardiovasc Imaging 6 2013 617 626
96. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
97. J.L. Schuller, C.M. Lowery, H.D. Weinberger, and W.H. Sauer Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis J Interv Card Electrophysiol 2009 July 23
98. N.Y. Hamzeh, F.S. Wamboldt, and H.D. Weinberger Management of cardiac sarcoidosis in the United States: a Delphi study Chest 141 2012 154 162
99. 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis J Nucl Cardiol 2013 December 3